Re: AACR April 24-29, 2020 for some Zenith Clinical Trial Results?
in response to
by
posted on
Apr 20, 2020 03:17PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Thx to tada and GP I found the PM I sent Feb11th.I was not far out in my memory.The first cohort started in August the 1st scan showed a 56 percent shrink the 2 scan 30 percent the 3rd remision